Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ruchika Husa, MD OSU Wexner Medical Center SCD and Therapeutic Hypothermia.

Similar presentations


Presentation on theme: "Ruchika Husa, MD OSU Wexner Medical Center SCD and Therapeutic Hypothermia."— Presentation transcript:

1 Ruchika Husa, MD OSU Wexner Medical Center SCD and Therapeutic Hypothermia

2 2 Clinical Vignette Young female found down by coworker in the UCSD temporary office building. No bystander CPR upon code teams arrival. pulseless, non-responsive. 2

3 00:45 Shock 1 02:45 Shock 2 05:30 Shock 3 08:30 Shock 4 10:30 Shock 5 11:45 Shock 6 ROSC Intubation

4 4 Post Resuscitation Cooled. Full neurologic recovery. No baseline ECG abnormalities. Cardiac MRI without anatomic abnormalities. ICD and discharge after 12 days. 4

5 Objectives Evidence behind therapeutic hypothermia Patient selection Methods of cooling Timing of cooling Degree of hypothermia Duration of hypothermia

6 Why should we cool?

7 7

8 Reperfusion Injury 3001020 Reperfusion Ischemia

9 Reperfusion injury Necrosis/apoptosis Inflammation Reactive oxygen species Improved defibrillation B-blocker effect? Why should we cool?

10 10 Historic perspective Open heart surgeries: moderate hypothermia (28C to 32C) used since the 1950s to protect the brain during intra-op global ischemia. Successful use of hypothermia after SCD described in 1950s but subsequently abandoned due to lack of evidence. 10

11 11 Cont. Guideline 2000 for CPR and Emergency Cardiovascular care did not include therapeutic hypothermia after arrest. In 2002 the results of 2 prospective randomized trials lead to addition of this recommendation to the guidelines. 11

12 Why should we cool?

13 13 Entry criteria: witnessed cardiac arrest with first resuscitation attempt 5-15 min after collapse, ROSC (<60 from collapse), persistent coma, VF. Exclusion criteria: severe cardiogenic shock, hypotension (SBP <90mmHg), persistent arrhythmias, primary coagulopathy. Approximately 92% of screened participants were excluded.

14 14 In European study, patients were cooled using a special mattress and ice packs. Target temp 32 ℃ to 34 ℃ for 24 hours. Rewarming over 8 hours. Australian study used cold packs in the field. Target temp 33 ℃ for 12 hours. Rewarming over 6 hours. PROTOCOL

15 Hypothermia After Cardiac Arrest Study Group (2002) NEJM Why should we cool?

16 16 OUTCOME NORMOTHERMIA HYPOTHERMIA RISK RATIO (95% CI)* P VALUE† no./total no. (%) Favorable neurologic 54/137 (39) 75/136 (55) 1.40 (1.08–1.81) 0.009 outcome Death 6/138 (55) 56/137 (41) 0.74 (0.58–0.95) 0.02 16 NEUROLOGIC OUTCOME AND MORTALITY AT SIX MONTHS

17 17 ALS Task Force recommendation in 2002 Unconscious adult patients with spontaneous circulation after out-of-hospital cardiac arrest should be cooled to 32 ℃ to 34 ℃ for 12-24 hours when initial rhythm was ventricular fibrillation. Such cooling may be beneficial for other rhythms or in-hospital cardiac arrest.

18 Why should we cool?

19 Cooling Emergency PCI Good ICU care Rehab? Post-Arrest Care

20 Sunde (2007) Resuscitation

21 21 Prognostic factors affecting survival with favorable outcomes Prognostic factors Adjusted odds ratio 95% CI Intervention period 4.47 1.60—12.52 Age >70 0.48 0.17—1.37 Time to ROSC 0.91 0.85—0.96 Ambulance response time 0.91 0.78—1.07 Initial VF 1.84 0.33—10.41

22 Post-Arrest Care

23 Does post-arrest cooling in the field really make that much difference? Should we be cooling during arrest? Does cooling distract from other tasks? Are there patients with complications from cooling that cannot be identified in the field? Prehospital Cooling Issues

24 Cellular approach Pre-treatment Necrosis/apoptosis Inflammation/ROS Pragmatic approach Intra-arrest Prehospital ROSC ED ICU When should we cool?

25 0123456789101112131415 Necrosis Apoptosis Days

26 When should we cool? Hypothermia After Cardiac Arrest Study Group (2002) NEJM

27 When should we cool? Abella (2004) Circulation

28 When should we cool? Kuboyama (1993) Crit Care Med

29 When should we cool? Nozari (2006) Circulation

30 When should we cool? Nozari (2006) Circulation

31 Prehospital Hypothermia

32 Kim (2007) Circulation

33 Prehospital Hypothermia Kim (2007) Circulation

34 All arrest victims? Brain doesn’t know the rhythm Only ventricular fibrillation? Evidence-based approach Non-VF patients? Infection CHF Bleeding Who should we cool?

35 35 Mild therapeutic hypothermia is associated with favourable outcome in patients after cardiac arrest with non-shockable rhythms Resuscitation - September 2011 - Retrospective analysis of adult cardiac arrest survivors suffering a witnessed out-of-hospital cardiac arrest with asystole or pulseless electric activity as the first documented rhythm. - Patients who were treated with mild therapeutic hypothermia were more likely to have good neurological outcomes, odds ratio of 1.84 (95% confidence interval: 1.08–3.13). - Mortality was significantly lower in the hypothermia group (odds ratio: 0.56; 95% confidence interval: 0.34–0.93).

36 36 Resuscitation - February 2012 Does therapeutic hypothermia benefit adult cardiac arrest patients presenting with non-shockable initial rhythms?: A systematic review and meta-analysis of randomized and non-randomized studies. TH is associated with reduced in-hospital mortality for adults patients resuscitated from non-shockable CA. However, most of the studies had substantial risks of bias and quality of evidence was very low. Further high quality randomized clinical trials would confirm the actual benefit of TH in this population. 36

37 Recent trial 37

38 Trial design Randomized 950 unconscious adults after out-of- hospital cardiac arrest of presumed cardiac cause (irrespective of initial rhythm) to targeted temperature management at either 33°C or 36°C. The primary outcome was all-cause mortality through the end of the trial. Secondary outcomes included a composite of poor neurologic function or death at 180 days 38

39 Body Temperature during the Intervention Period. Nielsen N et al. N Engl J Med 2013;369:2197-2206.

40 Probability of Survival through the End of the Trial. Nielsen N et al. N Engl J Med 2013;369:2197-2206.

41 Results 41

42 Complications of Hypothermia Coagulopathy Overshoot? Hemodynamic Dysrhythmias Infectious Sepsis, pneumonia Electrolyte disturbances

43 Who should we cool?

44 44

45 45

46 How should we cool? Surface cooling Evaporative Ice packs/chemical Cooling pads Internal strategies Cooled intravenous fluids Intravascular catheters Intranasal catheters

47 Cooling Catheters

48 Surface Cooling

49 How cold? Official recommendations Target temp 32-34 o C ? 36◦C Threshold for effect? Adverse effects? Really cold? Different mechanisms

50 50

51 Deep Hypothermia 20 min Circulatory Arrest

52 Deep Hypothermia

53 How long? Official recommendations Inflammatory pattern Peak at 72 hours Customized Depth and duration

54 How long?

55 55 Assessing neurologic recovery New thoughts on longer waiting time prior to withdrawal of care. 55

56 OOHCA with ROSC Iced saline in EMS or ED Cooling catheter  surface cooling with pads Median time from ED arrival to initiation of hypothermia < 30min Bladder temp probe Avoid shivering Aggressively control hyperthermia (fever) post rewarming. Suggested protocol

57 57

58 58

59 59

60 60

61 61

62 Parting Thoughts More patients should be closely monitored for hyperthermia The complications of hypothermia should be anticipated, not avoided Future research may help clarify the optimal “dose” and duration of hypothermia


Download ppt "Ruchika Husa, MD OSU Wexner Medical Center SCD and Therapeutic Hypothermia."

Similar presentations


Ads by Google